Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment‐resistant depression

Overview of attention for article published in Bipolar Disorders, January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 2 news outlets

twitter: 4 X users

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 34 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Esketamine-Nasal Spray Safe and Effective for Treatment-Resistant Bipolar Depression

Neurology Advisor , 17 Feb 2023

_.

Uno spray nasale contro la depressione nel disturbo bipolare

Insalute News, 31 Jan 2023

La Psichiatria dell’Università “d’Annunzio” protagonista nella ricerca di nuovi trattamenti antidepressivi.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.